Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat.

Vogelbacher, Regina; Meister, Silke; Gückel, Eva; Starke, Charlotte; Wittmann, Sandra; Stief, Andrea; Voll, Reinhard; Daniel, Christoph; Hugo, Christian

Vogelbacher, Regina; Meister, Silke; Gückel, Eva; Starke, Charlotte; Wittmann, Sandra; Stief, Andrea; Voll, Reinhard; Daniel, Christoph; Hugo, Christian.

Affiliation

Vogelbacher R; Medical Clinic IV (Nephrology), University of Erlangen-Nürnberg, Germany.

Nephrol Dial Transplant ; 25(11): 3764-73, 2010 Nov.

Article in En | MEDLINE | ID: mdl-20466656

Subject(s)

Boronic Acids/therapeutic use; Graft Rejection/prevention & control; Immunosuppressive Agents/therapeutic use; Isoantibodies/immunology; Kidney Transplantation/adverse effects; Pyrazines/therapeutic use; Sirolimus/therapeutic use; Animals; Bortezomib; Chronic Disease; Lymphocyte Depletion; Male; Plasma Cells/physiology; Rats; Rats, Inbred F344; Rats, Inbred Lew; Spleen/drug effects; Spleen/immunology; T-Lymphocytes/immunology; Transplantation, Homologous

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Kidney Transplantation / Sirolimus / Graft Rejection / Immunosuppressive Agents / Isoantibodies Limits: Animals Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2010 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google